O'Shaughnessy Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

O'Shaughnessy Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-769	Closed	-$92K	–	2382
2021 Q3	$92K	Buy	769 +254	+49%	+$28K	﹤0.01%	1402
2021 Q2	$50K	Buy	515 +476	+1,221%	+$42.4K	﹤0.01%	1579
2021 Q1	$3K	Buy	39 +6	+18%	+$558	﹤0.01%	2031
2020 Q4	$3K	Sell	33 -9	-21%	-$928	﹤0.01%	1800
2020 Q3	$5K	Buy	42 +9	+27%	+$946	﹤0.01%	1494
2020 Q2	$3K	Buy	+33	New	+$2.63K	﹤0.01%	1456
2020 Q1	–	Sell	-61	Closed	-$4K	–	1793
2019 Q4	$4K	Buy	+61	New	+$3.76K	﹤0.01%	1531

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

O'Shaughnessy Asset Management's TNDM Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Tandem Diabetes Care (TNDM) in Q4 2021, closing a stake of 769 shares — an estimated $92K sold.

O'Shaughnessy Asset Management first reported a position in TNDM in Q4 2019 and held it in 7 quarters. The position peaked at $92K in Q3 2021. 388 funds tracked by Wall St. Rank hold TNDM as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Tandem Diabetes Care position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 769 Tandem Diabetes Care shares in Q4 2021, an estimated $92K.
O'Shaughnessy Asset Management first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 7 quarters.
O'Shaughnessy Asset Management's Tandem Diabetes Care position peaked at $92K in Q3 2021.
388 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.